Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
2(11%)
Results Posted
60%(6 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_4
1
6%
Ph not_applicable
6
33%
Ph phase_1
2
11%
Ph early_phase_1
2
11%
Ph phase_2
5
28%

Phase Distribution

4

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
2(12.5%)
Phase 1Safety & dosage
2(12.5%)
Phase 2Efficacy & side effects
5(31.3%)
Phase 4Post-market surveillance
1(6.3%)
N/ANon-phased studies
6(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

18

all time

Status Distribution
Active(2)
Completed(10)
Terminated(1)
Other(5)

Detailed Status

Completed10
unknown5
Active, not recruiting1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
2
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (12.5%)
Phase 12 (12.5%)
Phase 25 (31.3%)
Phase 41 (6.3%)
N/A6 (37.5%)

Trials by Status

unknown528%
active_not_recruiting16%
completed1056%
recruiting16%
terminated16%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT04729322Phase 2

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Active Not Recruiting
NCT07490054Phase 1

Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure

Recruiting
NCT07286851

Do Topical Antibiotics Improve Skin Graft Results?

Completed
NCT02765256Phase 2

Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease

Completed
NCT02730962Phase 2

Interventional Bioremediation of Microbiota in Metabolic Syndrome

Terminated
NCT05593601Phase 4

Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin

Unknown
NCT03476317Phase 2

Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease

Completed
NCT03593252Not Applicable

Bowel Preparation in Elective Pediatric Colorectal Surgery

Unknown
NCT01638429Early Phase 1

Role of Methane in Glycemic Control

Completed
NCT03042091Early Phase 1

Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery

Unknown
NCT02154061Not Applicable

Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics

Completed
NCT02472600Phase 2

Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal Bacteriotherapy

Unknown
NCT02604849

Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin

Completed
NCT02001909Phase 1

Effect of Neomycin on the Pharmacokinetics of Regorafenib

Completed
NCT00945334Not Applicable

Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome

Completed
NCT00166868Not Applicable

Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy

Completed
NCT01097811Not Applicable

Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy

Unknown
NCT00355602Not Applicable

Antibiotics for the Treatment of Ulcerative Colitis

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18